AKER BP NK 1/ NO0010345853 /
26/04/2024 21:43:04 | Chg. -0.020 | Volume | Bid26/04/2024 | Demandez à26/04/2024 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
24.060EUR | -0.08% | 0 Chiffrre d'affaires: 0.000 |
-Bid taille: - | -Ask la taille: - | 15.29 Mrd.EUR | - | - |
Newsfile Corp
03:20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Che...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocu...
GlobeNewswire
02:40
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to ...
GlobeNewswire
02:17
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with L...
Newsfile Corp
01:11
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Se...
Newsfile Corp
28/04
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Befor...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page